Best Buy to sell over-the-counter hearing devices this fall following change in FDA regulation

Best Buy to sell over-the-counter hearing devices this fall following change in FDA regulation


Black Friday shoppers leave a Best Buy store in Washington, DC, on November 26, 20221.

Nicholas Kamm | AFP | Getty Images

Best Buy said Wednesday that it will offer an expanded collection of hearing products and services this fall after federal regulators said they would begin allowing sales of over-the-counter hearing devices.

By fall, the Minneapolis-based company said 300 of its more than 1,000 stores will have hearing solutions displays with about 10 hearing devices available at each. The electronic products retailer said it has already started offering an online hearing assessment tool.

The push by Best Buy comes after the U.S. Food and Drug Administration this week greenlit sales of over-the-counter hearing devices, which the agency said will let people with mild to moderate hearing loss buy devices from retailers without needing a medical exam, prescription, or fitting adjustment. The FDA will still regulate the quality of the OTC devices, which it said could be available as early as mid-October when the rule takes effect.

Hearing aids that are intended for severe hearing impairment or for people younger than 18 still require prescriptions.

The FDA said the new rule is expected to lower the cost of hearing aids. Nearly 30 million adults in the U.S. could benefit from hearing aids, according the agency.

Best Buy has sold hearing devices including personal sound amplification products, TV amplifiers and hearing protection devices, but the new category of OTC devices opens the door for new products. 

Customers will be able to use health savings accounts and flexible spending accounts to purchase devices. Best Buy recommends checking with insurance providers to confirm the devices are covered.

“Our expansion of the hearing collection and new store experience will let customers easily find a hearing loss solution from brands they trust,” said Frank Bedo, category officer at Best Buy, in a statement.

Best Buy was down around 2% in pre-market trading. 



Source

Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here
Health

Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here

Wall Street is optimistic that Olema Pharmaceutical could be developing the next major breakthrough breast cancer treatment. Earlier this month, the company announced promising clinical data for its lead candidate palazestrant, an oral medication that is being evaluated in several trials for estrogen receptor-positive, or ER+, breast cancer. Shares of the clinical-stage biopharmaceutical company are up […]

Read More
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’
Health

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’

It’s been a stellar few months for shares of San Francisco-based biotech company Rigel Pharmaceuticals, which has approved treatments for rheumatology and oncology — as well as potential new drugs in the pipeline. The stock has jumped about 50% in just the last three months, earning it a spot on CNBC’s list of top performing […]

Read More
We’re raising our Eli Lilly price target — what a difference a quarter makes
Health

We’re raising our Eli Lilly price target — what a difference a quarter makes

Eli Lilly shares jumped Thursday after the drugmaker posted a strong third quarter, driven by sales of its popular GLP-1 medications. The company also raised its full-year sales outlook for the second time in a row, inspiring confidence in the trajectory of the franchise. Revenue in the three months ended Sept. 30 jumped 54% year […]

Read More